Investors
- Financial Reports
News
- Press Release
English
Swedish

Year-end Report 2021

February 24, 2022

Year-end Report 2021

Share

Email
Twitter
Facebook
Google +
Pinterest
Tumblr
Linkedin
Vkontakte

Press

Follicum reports revised top-line results from the Phase IIa study of FOL-005 for the treatment of hair loss (alopecia) June 24, 2021

Follicum appoints Jonas Edelswärd as new CFO May 10, 2021

Follicum reports top-line results from Phase IIa study of FOL-005 for treatment of hair loss (alopecia) May 6, 2021

Contact – Coegin Pharma AB

Medicon Village, 223 81 Lund

+45 61 90 50 66

info@coeginpharma.com

Org. Nr.: 559078-0465

Copyright © 2018 - Follicum AB